Just the Facts: Recce Pharmaceuticals scores 93% efficacy in Phase II trial

By Proactive Investors / February 17, 2025 / www.youtube.com / Article Link

Recce Pharmaceuticals Ltd has received positive Phase II clinical trial results for RECCE(R) 327 Topical Gel (R327G) in treating ...

Recent News

AOCE and WB boost gold targets for 2025 significantly

November 10, 2025 / www.canadianminingreport.com

Gold and silver price ETFs see major net outflows

November 04, 2025 / canadianminingreport.com

Gold stocks decline by less than metal price

November 04, 2025 / www.canadianminingreport.com

A shift to the later stages of gold and silver bull markets

October 27, 2025 / www.canadianminingreport.com

Gold stocks plunge on metal drop

October 27, 2025 / www.canadianminingreport.com

See all >